Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

Mutations of the BRAF gene in human cancer

Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674

In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2

Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., & Parks, W. P. (1973) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1417 · Cited by 2,336

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.

Kimura, E. T., Nikiforova, M. N., Zhu, Z., Knauf, J. A., Nikiforov, Y. E., & Fagin, J. A. (2003) · PubMed · Cited by 1,510

BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas

Nikiforova, M. N., Kimura, E. T., Gandhi, M., Biddinger, P. W., Knauf, J. A., Basolo, F., Zhu, Z., Giannini, R., Salvatore, G., Fusco, A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030838 · Cited by 1,036

New Human Tumor Cell Lines

Fogh, J., & Trempe, G. (1975) · Springer eBooks · doi:10.1007/978-1-4757-1647-4_5 · Cited by 1,034

Molecular characterization of human prostate carcinoma cell lines

van Bokhoven, A., Varella‐Garcia, M., Korch, C. T., Johannes, W. U., Smith, E. E., Miller, H. L., Nordeen, S. K., Miller, G. J., & Lucia, M. S. (2003) · The Prostate · doi:10.1002/pros.10290 · Cited by 635

Clinical Implication of Hot SpotBRAFMutation, V599E, in Papillary Thyroid Cancers

Namba, H., Nakashima, M., Hayashi, T., Hayashida, N., Maeda, S., Rogounovitch, T., Ohtsuru, A., Saenko, V., Kanematsu, T., & Yamashita, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030305 · Cited by 532

Short tandem repeat profiling provides an international reference standard for human cell lines

Masters, J. R., Thomson, J. A., Daly-Burns, B., Reid, Y. A., Dirks, W. G., Packer, P., Toji, L. H., Ohno, T., Tanabe, H., Arlett, C. F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121616198 · Cited by 478

The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines

Lavarone, E., Puppin, C., Passon, N., Filetti, S., Russo, D., & Damante, G. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.019 · Cited by 24

Regulation of Uptake of18F-FDG by a Follicular Human Thyroid Cancer Cell Line with Mutation-Activated K-Ras

Prante, O., Maschauer, S., Frémont, V., Reinfelder, J., Stoehr, R., Szkudlinski, M. W., Weintraub, B. D., Hartmann, A., & Kuwert, T. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.062331 · Cited by 24

Dedifferentiation of Human Primary Thyrocytes into Multilineage Progenitor Cells without Gene Introduction

Suzuki, K., Mitsutake, N., Saenko, V., Suzuki, M., Matsuse, M., Ohtsuru, A., Kumagai, A., Uga, T., Yano, H., Nagayama, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019354 · Cited by 24

Telomerase-Driven Expression of the Sodium Iodide Symporter (NIS) for in Vivo Radioiodide Treatment of Cancer: A New Broad-Spectrum NIS-Mediated Antitumor Approach

Riesco‐Eizaguirre, G., la Vieja, A. D., Rodrı́guez, I., Miranda, S., Martín‐Duque, P., Vassaux, G., & Santisteban, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2373 · Cited by 24

Paired Box Gene 8-Peroxisome Proliferator-Activated Receptor-γ Fusion Protein and Loss of Phosphatase and Tensin Homolog Synergistically Cause Thyroid Hyperplasia in Transgenic Mice

Diallo, E. M., Yu, J., Colby, L. A., Inoki, K., Wilkinson, J. E., Thomas, D. G., Giordano, T. J., & Koenig, R. J. (2009) · Endocrinology · doi:10.1210/en.2009-0701 · Cited by 24

Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation

Jang, S., Yu, X.-M., Odorico, S. K., Clark, M., Jaskula‐Sztul, R., Schienebeck, C. M., Kupcho, K. R., Harrison, A. D., Winston‐McPherson, G. N., Tang, W., et al. (2015) · Cancer Gene Therapy · doi:10.1038/cgt.2015.37 · Cited by 24

Digitalis-like Compounds Facilitate Non-Medullary Thyroid Cancer Redifferentiation through Intracellular Ca2+, FOS, and Autophagy-Dependent Pathways

Tesselaar, M. H., Crezee, T., Swarts, H. G. P., Gerrits, D., Boerman, O. C., Koenderink, J. B., Stunnenberg, H. G., Netea, M. G., Smit, J. W. A., Netea-Maier, R. T., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0460 · Cited by 23

Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene

Montero‐Conde, C., Leandro-Garcia, L. J., Chen, X., Oler, G., Ruiz‐Llorente, S., Ryder, M. M., Landa, I., Sánchez-Vega, F., La, K., Ghossein, R. A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702723114 · Cited by 24

Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation

Cao, Y.-M., Gu, J. F., Zhang, Y.-S., Wei, W., Qu, N., Wen, D., Liao, T., Shi, R., Zhang, L., Ji, Q., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.6058 · Cited by 24

Induction of Heparanase-1 Expression by Mutant B-Raf Kinase: Role of GA Binding Protein in Heparanase-1 Promoter Activation

Rao, G., Liu, D., Xing, M., Tauler, J., Prinz, R. A., & Xu, X. (2010) · Neoplasia · doi:10.1593/neo.10790 · Cited by 24

3,3'-Diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways

Tiwari (2010) · Oncology Reports · doi:10.3892/or.2010.1076 · Cited by 24

The Extensive and Expensive Impacts of HEp-2 [HeLa], Intestine 407 [HeLa], and Other False Cell Lines in Journal Publications

Korch, C. T., & Capes-Davis, A. (2021) · SLAS Discovery · doi:10.1177/24725552211051963 · Cited by 23

Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas

Chaker, S., Kashat, L., Voisin, S. N., Kaur, J., Kak, I., MacMillan, C., Özçelik, H., Siu, K. W. M., Ralhan, R., & Walfish, P. G. (2013) · PROTEOMICS · doi:10.1002/pmic.201200356 · Cited by 23

Aberrant L1 Cell Adhesion Molecule Affects Tumor Behavior and Chemosensitivity in Anaplastic Thyroid Carcinoma

Kim, K. S., Min, J., Liang, Z. L., Lee, K., Lee, J. U., Bae, K., Lee, M. H., Lee, S. E., Ryu, M. J., Kim, S. J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2757 · Cited by 23

The efficacy of HRAS and CDK4/6 inhibitors in anaplastic thyroid cancer cell lines

Lopes-Ventura, S., Pojo, M., Matias, A. T., Moura, M. M., Marques, I. J., Leite, V. A. P. H., & Cavaco, B. M. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0947-4 · Cited by 26

hsa_circ_0001018 promotes papillary thyroid cancer by facilitating cell survival, invasion, G1/S cell cycle progression, and repressing cell apoptosis via crosstalk with miR-338-3p and SOX4

Luo, Q., Guo, F., Fu, Q., & Sui, G. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.02.023 · Cited by 23

Akt inhibition enhances the cytotoxic effect of apigenin in combination with PLX4032 in anaplastic thyroid carcinoma cells harboring BRAFV600E.

Kim, S. H., Kang, J. G., Kim, C. S., Ihm, S., Choi, M. G., Yoo, H. J., & Lee, S. (2013) · PubMed · doi:10.3275/9099 · Cited by 23

Aberrant Promoter Methylation in Overexpression of CITED1 in Papillary Thyroid Cancer

Sassa, M., Hayashi, Y., Watanabe, R., Kikumori, T., Imai, T., Kurebayashi, J., Kiuchi, T., & Murata, Y. (2011) · Thyroid · doi:10.1089/thy.2010.0295 · Cited by 23

Humanized Medium (h7H) Allows Long-Term Primary Follicular Thyroid Cultures From Human Normal Thyroid, Benign Neoplasm, and Cancer

Bravo, S. B., García-Rendueles, M. E. R., Garcia-Rendueles, Á. R., Rodrigues, J. S., Pérez-Romero, S., García-Lavandeira, M., Suarez-Fariña, M., Barreiro, F. J. J., Czarnocka, B., Senra, A., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3812 · Cited by 23

Human sodium–iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells

Li, W., & Ain, K. B. (2010) · Endocrine Related Cancer · doi:10.1677/erc-09-0156 · Cited by 23

Role of reduced expression of SMAD4 in papillary thyroid carcinoma

D'inzeo, S., Nicolussi, A., Ricci, A., Mancini, P., Porcellini, A., Nardi, F., & Coppa, A. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0044 · Cited by 23

The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer

Beadnell, T. C., Mishall, K. M., Zhou, Q., Riffert, S. M., Wuensch, K. E., Kessler, B. E., Corpuz, M. L., Jing, X., Kim, J., Wang, G., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0702 · Cited by 23

Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancers

Matos, D. M. C., Jang, S., Hijaz, B. A., Chang, A. W., Lloyd, R. V., Chen, H., & Jaskula‐Sztul, R. (2018) · Surgery · doi:10.1016/j.surg.2018.05.077 · Cited by 23

COPZ1 depletion in thyroid tumor cells triggers type I IFN response and immunogenic cell death

Marco, T. D., Bianchi, F., Sfondrini, L., Todoerti, K., Bongarzone, I., Maffioli, E., Tedeschi, G., Mazzoni, M., Pagliardini, S., Pellegrini, S., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.011 · Cited by 23

Unraveling the Roles of miR-204-5p and HMGA2 in Papillary Thyroid Cancer Tumorigenesis

Branteghem, C. V., Augenlicht, A., Demetter, P., Craciun, L., & Maenhaut, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310764 · Cited by 22

PDE5 Inhibitors-Loaded Nanovesicles: Physico-Chemical Properties and In Vitro Antiproliferative Activity

Rose, R. F. D., Cristiano, M. C., Celano, M., Maggisano, V., Vero, A., Lombardo, G. E., Francesco, M. D., Paolino, D., Russo, D., & Cosco, D. (2016) · Nanomaterials · doi:10.3390/nano6050092 · Cited by 22

Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer

Tesselaar, M. H., Crezee, T., Schuurmans, I. M. E., Gerrits, D., Nagarajah, J., Boerman, O. C., Grunsven, I. V. E., Smit, J. W. A., Netea-Maier, R. T., & Plantinga, T. S. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.200675 · Cited by 22

Sphingosine 1-phosphate attenuates MMP2 and MMP9 in human anaplastic thyroid cancer C643 cells: Importance of S1P2

Asghar, M. Y., Kemppainen, K., Lassila, T., & Törnquist, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196992 · Cited by 22

Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial–Mesenchymal Transition of Thyroid Carcinoma Cells

Kim, S. H., Kang, J. G., Kim, C. S., Ihm, S., Choi, M. G., & Lee, S. J. (2018) · Anticancer Research · doi:10.21873/anticanres.12992 · Cited by 22

ZIP10 is a negative determinant for anti-tumor effect of mannose in thyroid cancer by activating phosphate mannose isomerase

Ma, S., Wang, N., Liu, R., Zhang, R., Dang, H., Wang, Y., Wang, S., Zeng, Z., Ji, M., & Hou, P. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02195-z · Cited by 21

Induction of Thyroid Gene Expression and Radioiodine Uptake in Melanoma Cells: Novel Therapeutic Implications

Hou, P., Liu, D., Ji, M., Liu, Z., Engles, J. M., Wahl, R. L., & Xing, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006200 · Cited by 21

Genotype-dependent cooperation of ionizing radiation with BRAF inhibition in BRAF V600E-mutated carcinomas

Dasgupta, T., Haas-Kogan, D. A., Yang, X., Olow, A., Yang, D. X., Gragg, A., Orloff, L. A., & Yom, S. S. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-9928-9 · Cited by 21

Establishment, Characterization and Comparison of Seven Authentic Anaplastic Thyroid Cancer Cell Lines Retaining Clinical Features of the Original Tumors

Onoda, N., Nakamura, M., Aomatsu, N., Noda, S., Kashiwagi, S., & Hirakawa, K. (2013) · World Journal of Surgery · doi:10.1007/s00268-013-2409-7 · Cited by 21

2D- and 3D-cell culture

Хоруженко, А. І. (2011) · Biopolymers and Cell · doi:10.7124/bc.00007d · Cited by 21

Dsg2-mediated c-Met activation in anaplastic thyroid cancer motility and invasion

Lee, K.-M., Lee, S., Kim, W., Lee, J., Park, J., Kim, J., Kim, J. T., Kang, Y. E., Shong, M., Lee, H. J., et al. (2020) · Endocrine Related Cancer · doi:10.1530/erc-19-0403 · Cited by 21

Primary Cell Culture Systems for Human Thyroid Studies

Wang, Y., Li, W., Phay, J. E., Shen, R. Z., Pellegata, N. S., Saji, M., Ringel, M. D., de la Chapelle, A., & He, H. (2016) · Thyroid · doi:10.1089/thy.2015.0518 · Cited by 21

Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells

Celano, M., Maggisano, V., Lepore, S. M., Sponziello, M., Pecce, V., Verrienti, A., Durante, C., Maranghi, M., Lucia, P., Bulotta, S., et al. (2019) · International Journal of Endocrinology · doi:10.1155/2019/5031696 · Cited by 21

S100A1 is a Potential Biomarker for Papillary Thyroid Carcinoma Diagnosis and Prognosis

Wang, G., Li, H., Cui, X., Xu, T., Dong, M., Li, S., & Li, X. (2021) · Journal of Cancer · doi:10.7150/jca.51855 · Cited by 20

Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells

Ohno, K., Shibata, T., & Ito, K. (2022) · Cancer Science · doi:10.1111/cas.15465 · Cited by 20

Cell line misidentification: the beginning of the end

Masters, J. R. W. (2010) · UCL Discovery (University College London) · Cited by 20

Regulation of leptin receptor expression in human papillary thyroid cancer cells

Cheng, S., Liu, C., Hsu, Y., Chang, Y., Huang, S., & Lee, J.-J. (2012) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2012.03.008 · Cited by 20

Ionizing radiation enhances dl922–947-mediated cell death of anaplastic thyroid carcinoma cells

Passaro, C., Abagnale, A., Libertini, S., Volpe, M., Botta, G., Cella, L., Pacelli, R., Halldén, G., Gillespie, D. A., & Portella, G. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0001 · Cited by 20

Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer

Celano, M., Mio, C., Sponziello, M., Verrienti, A., Bulotta, S., Durante, C., Damante, G., & Russo, D. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.036 · Cited by 21

IL13RA2 Is Differentially Regulated in Papillary Thyroid Carcinoma vs Follicular Thyroid Carcinoma

Chong, S. T., Tan, K. M., Kok, C. Y. L., Guan, S. P., Lai, S. H., Lim, C., Hu, J., Sturgis, C. D., Eng, C., Lam, P. Y. P., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00040 · Cited by 20

Diallyl trisulphide, a H 2 S donor, compromises the stem cell phenotype and restores thyroid‐specific gene expression in anaplastic thyroid carcinoma cells by targeting AKT‐SOX2 axis

Zhang, L., Xu, S., Cheng, X. F., Zheng, J., Wang, Y., Wu, J., Wang, X., Wu, L., Yu, H., & Bao, J. (2021) · Phytotherapy Research · doi:10.1002/ptr.7065 · Cited by 20

Differential Effects of Estrogen Receptor Alpha and Beta on Endogenous Ligands of Peroxisome Proliferator-Activated Receptor Gamma in Papillary Thyroid Cancer

Yang, S., Gong, Z., Liu, Z., Wei, M., Xue, L., Vlantis, A. C., Zhang, Y., Chan, J. Y. K., van Hasselt, C. A., Zeng, X., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.708248 · Cited by 20

Expression of Stanniocalcin 1 in Thyroid Side Population Cells and Thyroid Cancer Cells

Hayase, S., Sasaki, Y., Matsubara, T., Seo, D., Miyakoshi, M., Murata, T., Ozaki, T., Kakudo, K., Kumamoto, K., Ylaya, K., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0464 · Cited by 20

Implication of Oxygen-Regulated Protein 150 (ORP150) in Apoptosis Induced by Proteasome Inhibitors in Human Thyroid Cancer Cells

Gao, Y., Liu, B.-Q., Du, Z., Zhang, H.-Y., Niu, X., & Wang, H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1043 · Cited by 20

Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expression

Klopper, J. P., Sharma, V., Berenz, A., Hays, W. R., Loi, M. M., Pugazhenthi, U., Said, S., & Haugen, B. R. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-16 · Cited by 20

Follicular thyroid carcinoma but not adenoma recruits tumor-associated macrophages by releasing CCL15

Huang, F., Zhou, X., Ye, L., Fei, X., Wang, S., Wang, W., & Ning, G. (2016) · BMC Cancer · doi:10.1186/s12885-016-2114-7 · Cited by 20

Optimization of cell lines as tumour models by integrating multi-omics data

Zhao, N., Liu, Y., Wei, Y., Yan, Z., Zhang, Q., Wu, C., Chang, Z., & Xu, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw082 · Cited by 20

Hif-1α Inhibitors Could Successfully Inhibit the Progression of Differentiated Thyroid Cancer in Vitro

Kim, M., Lee, T. H., Lee, J. S., Lim, D., & Lee, P. C.-W. (2020) · Pharmaceuticals · doi:10.3390/ph13090208 · Cited by 19

RAP1GAP inhibits cytoskeletal remodeling and motility in thyroid cancer cells

Dong, X., Tang, W., Stopenski, S. J., Brose, M. S., Korch, C. T., & Meinkoth, J. L. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0086 · Cited by 19

Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse Models

Reddi, H. V., Madde, P., Cohen, Y. C., Bangio, L., Breitbart, E., Harats, D., Bible, K. C., & Eberhardt, N. L. (2011) · Genes & Cancer · doi:10.1177/1947601912437933 · Cited by 19

Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo

Zhang, K., Yu, M., Hao, F., Dong, A., & Chen, D. (2016) · Cancer Biomarkers · doi:10.3233/cbm-160640 · Cited by 19

A dual mechanism of activation of the Sonic Hedgehog pathway in anaplastic thyroid cancer: crosstalk with RAS-BRAF-MEK pathway and ligand secretion by tumor stroma

Parascandolo, A., Laukkanen, M. O., Rosa, N. D., Ugolini, C., Cantisani, M. C., Cirafici, A. M., Basolo, F., Santoro, M. M., & Castellone, M. D. (2017) · Oncotarget · doi:10.18632/oncotarget.23388 · Cited by 19

Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?

Urra, S., Fischer, M. C., Martínez, J. R. W., Véliz, L. P., Orellana, P., Solar, A. A., Böhmwald, K., Kalergis, A. M., Riedel, C. A., Corvalán, A. H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23502 · Cited by 19

Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts

Marlow, L. A., Rohl, S. D., Miller, J. L., Knauf, J. A., Fagin, J. A., Ryder, M. M., Milosevic, D., Netzel, B. C., Grebe, S. K. G., Reddi, H. V., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01845 · Cited by 19

Multiple proliferation-survival signalling pathways are simultaneously active in BRAF V600E mutated thyroid carcinomas

Rahman, M. A., Salajegheh, A., Smith, R. A., & Lam, A. K.-Y. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.09.006 · Cited by 19

Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivo

Chan, D. (2012) · Oncology Letters · doi:10.3892/ol.2012.579 · Cited by 19

The paramount role of cytokines and chemokines in papillary thyroid cancer: a review and experimental results

Fallahi, P., Ferrari, S. M., Piaggi, S., Luconi, M., Cantini, G., Gelmini, S., Elia, G., Ruffilli, I., & Antonelli, A. (2018) · Immunologic Research · doi:10.1007/s12026-018-9056-x · Cited by 19

Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis

McLaughlin, P. J., Zagon, I. S., Park, S. S., Conway, A. B., Donahue, R. N., & Goldenberg, D. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-369 · Cited by 19

The Significance of TROP2 Expression in Predicting BRAF Mutations in Papillary Thyroid Carcinoma

Kong, J. S., Kim, H. J., Kim, M., Kim, A., Lee, D., Han, K., Park, S., Koh, J. S., & Myung, J. K. (2017) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2017.10.17 · Cited by 18

Nevirapine Increases Sodium/Iodide Symporter-Mediated Radioiodide Uptake by Activation of TSHR/cAMP/CREB/PAX8 Signaling Pathway in Dedifferentiated Thyroid Cancer

Shang, H., Zhao, J., Yao, J., Wang, H. J., Dong, J., & Liao, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00404 · Cited by 19

Presence of complete murine viral genome sequences in patient-derived xenografts

Yuan, Z., Fan, X., Zhu, J., Fu, T., Wu, J., Xu, H., Zhang, N., An, Z., & Zheng, W. J. (2021) · Nature Communications · doi:10.1038/s41467-021-22200-5 · Cited by 17

Downregulation of lncRNA ZFAS1 inhibits the hallmarks of thyroid carcinoma via the regulation of miR‑302‑3p on cyclin D1

Chen, W., Zhai, L., Liu, H., Li, Y., Zhang, Q., Xu, D., & Fan, W. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11640 · Cited by 18

Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells

Allegri, L., Baldan, F., Mio, C., Puppin, C., Russo, D., Kryštof, V., & Damante, G. (2016) · Oncology Reports · doi:10.3892/or.2016.4614 · Cited by 18

Establishment, authenticity, and characterization of cervical cancer cell lines

Martinez, M. D. L. Z., Mendoza, C. M. L., Salazar, J. T., García-Carrancá, A. M., Cervantes, M. A. C., & Alcántara-Quintana, L. E. (2022) · Molecular & Cellular Oncology · doi:10.1080/23723556.2022.2078628 · Cited by 17

The effect of 17-allylamino-17-demethoxygeldanamycin alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells

Kim, S. H., Kang, J. G., Kim, C. S., Ihm, S., Choi, M. G., Yoo, H. J., & Lee, S. J. (2014) · Endocrine · doi:10.1007/s12020-014-0371-2 · Cited by 17

Iodine-Deficiency-Induced Long Lasting Angiogenic Reaction in Thyroid Cancers Occurs Via a Vascular Endothelial Growth Factor–Hypoxia Inducible Factor-1–Dependent, But Not a Reactive Oxygen Species–Dependent, Pathway

Gérard, A.-C., Humblet, K., Wilvers, C., Poncin, S., Derradji, H., de Goyet, C. D. V., Abou‐El‐Ardat, K., Baatout, S., Sonveaux, P., Denef, J., et al. (2012) · Thyroid · doi:10.1089/thy.2011.0387 · Cited by 17

In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription

Puppin, C., Passon, N., Frasca, F., Vigneri, R., Tomay, F., Tomaciello, S., & Damante, G. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0009-9 · Cited by 16

Sphingosine 1-phosphate and human ether-a′-go-go-related gene potassium channels modulate migration in human anaplastic thyroid cancer cells

Asghar, M. Y., Viitanen, T., Kemppainen, K., & Törnquist, K. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0092 · Cited by 17

Tackling the Human Cell Line and Tissue Misidentification Problem Is Needed for Reproducible Biomedical Research

Korch, C. T., & Varella‐Garcia, M. (2018) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2018.07.003 · Cited by 16

Efficacy of adavosertib therapy against anaplastic thyroid cancer

Lu, Y., Huang, Y., Wu, M., Chou, T., Wong, R. J., & Lin, S. (2021) · Endocrine Related Cancer · doi:10.1530/erc-21-0001 · Cited by 16

Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer

de Mello, D. C., Saito, K. C., Cristovão, M. M., Kimura, E. T., & Fuziwara, C. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097872 · Cited by 16

Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers

Schweppe, R. E., Pozdeyev, N. V., Pike, L. A., Korch, C. T., Zhou, Q., Sams, S. B., Sharma, V., Pugazhenthi, U., Raeburn, C. D., Albuja-Cruz, M. B., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1026 · Cited by 16

Cationic carboxylate and thioacetate ruthenium( ii ) complexes: synthesis and cytotoxic activity against anaplastic thyroid cancer cells

Lovison, D., Allegri, L., Baldan, F., Ballico, M., Damante, G., Jandl, C., & Baratta, W. (2020) · Dalton Transactions · doi:10.1039/d0dt01390k · Cited by 16

FTY720 (Fingolimod) attenuates basal and sphingosine-1-phosphate-evoked thyroid cancer cell invasion

Kalhori, V., Magnuson, M., Asghar, M. Y., Pulli, I., & Törnquist, K. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0050 · Cited by 16

The Knockdown of Nrf2 Suppressed Tumor Growth and Increased the Sensitivity to Lenvatinib in Anaplastic Thyroid Cancer

Gong, Z., Xue, L., Wei, M., Liu, Z., Vlantis, A. C., van Hasselt, C. A., Chan, J. Y. K., Li, D., Zeng, X., Tong, M. C. F., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3900330 · Cited by 16

“Thyroid Cancer” Cell Line Misidentification: A Time for Proactive Change

Ringel, M. D. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2008 · Cited by 16

Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2

Gong, Z., Xue, L., Vlantis, A. C., van Hasselt, C. A., Chan, J., Fang, J., Wang, R., Yang, Y., Li, D., Zeng, X., et al. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02248-4 · Cited by 15

Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinoma

Plantinga, T. S., Petrulea, M. S., Oosting, M., Joosten, L. A. B., Piciu, D., Smit, J. W. A., Netea-Maier, R. T., & Georgescu, C. E. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0033 · Cited by 15

Preclinical Models of Follicular Cell-Derived Thyroid Cancer: An Overview from Cancer Cell Lines to Mouse Models

Jeon, M. J., & Haugen, B. R. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1636 · Cited by 15

BRAF activates and physically interacts with PAK to regulate cell motility

McCarty, S., Saji, M., Zhang, X., Knippler, C. M., Kirschner, L. S., Fernández, S., & Ringel, M. D. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0424 · Cited by 15

Misidentification of OLGA-PH-J/92, believed to be the only crustacean cell line

Lee, L. E. J., Bufalino, M. R., Christie, A. E., Frischer, M. E., Soin, T., Tsui, C. K. M., Hanner, R., & Smagghe, G. J. (2011) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-011-9447-y · Cited by 15

Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells

Damante, G. (2010) · Oncology Reports · doi:10.3892/or.2010.1075 · Cited by 15

Inhibition of Mnk–eIF4E Pathway Sensitizes The Efficacy to Chemotherapy in Anaplastic Thyroid Cancer

Hu, K., Zhang, J., Yu, M., & Xiong, C. (2016) · Future Oncology · doi:10.2217/fon-2016-0320 · Cited by 15

Combination PPAR γ and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2

Klopper, J. P., Sharma, V., Bissonnette, R. P., & Haugen, B. R. (2009) · PPAR Research · doi:10.1155/2010/729876 · Cited by 15

A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability

Cantisani, M. C., Parascandolo, A., Perälä, M., Allocca, C., Fey, V., Sahlberg, N., Merolla, F., Basolo, F., Laukkanen, M. O., Kallioniemi, O., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8577 · Cited by 14

Tumor–mast cell interactions: Induction of pro-tumorigenic genes and anti-tumorigenic 4-1BB in MCs in response to Lewis Lung Carcinoma

Wensman, H., Kamgari, N., Alsing-Johansson, T., Grujić, M., Calounova, G., Lundequist, A., Rönnberg, E., & Pejler, G. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.01.009 · Cited by 14

The Tyrosine Kinase Inhibitor Imatinib Augments Extracellular Fluid Exchange and Reduces Average Collagen Fibril Diameter in Experimental Carcinoma

Olsson, P. O., Gustafsson, R., Zandt, R. I. ‘., Friman, T., Maccarana, M., Tykesson, E., Oldberg, Å., Rubin, K., & Kalamajski, S. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0026 · Cited by 14

Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity

Maniakas, A., Henderson, Y. C., Hei, H., Peng, S., Chen, Y., Jiang, Y., Ji, S., Cardenas, M., Chiu, Y., Bell, D., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab453 · Cited by 14

Papillary Carcinoma of the Thyroid: High Expression of COX-2 and Low Expression of KAI-1/CD82 Are Associated with Increased Tumor Invasiveness

Scarpino, S., Duranti, E., Giglio, S., Napoli, A. D., Galafate, D., Bufalo, D. D., Desideri, M., Socciarelli, F., Stoppacciaro, A., & Ruco, L. (2013) · Thyroid · doi:10.1089/thy.2011.0421 · Cited by 14

Establishment and Molecular Cytogenetic Characterization of a Cell Culture Model of Head and Neck Squamous Cell Carcinoma (HNSCC)

Bauer, V. L., Hieber, L., Schaeffner, Q., Weber, J., Braselmann, H., Huber, R., Walch, A. K., & Zitzelsberger, H. F. (2010) · Genes · doi:10.3390/genes1030388 · Cited by 14

Vitamin D inhibits CEACAM1 to promote insulin/IGF-I receptor signaling without compromising anti-proliferative action

Liu, W., Guo, M., Ezzat, S., & Asa, S. L. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.144 · Cited by 14

Nanomedicine mediated thyroid cancer diagnosis and treatment: an approach from generalized to personalized medicine

Gulwani, D., Upadhyay, P., Goel, R., Sarangthem, V., & Singh, T. D. (2024) · Discover Oncology · doi:10.1007/s12672-024-01677-8 · Cited by 13

Inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs response of cancer cells to DR5-mediated apoptosis and T cell-induced killing

Oh, Y.-T., Deng, J., Yue, P., Owonikoko, T. K., Khuri, F. R., & Sun, S.-Y. (2015) · Oncogene · doi:10.1038/onc.2015.97 · Cited by 13

Thyroid cancer cell lines: Critical models to study thyroid cancer biology and new therapeutic targets

Schweppe, R. E. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00081 · Cited by 13

CITED1 gene promotes proliferation, migration and invasion in papillary thyroid cancer

Xia, E., Wang, Y., Bhandari, A., Niu, J., Yang, F., Yao, Z., & Wang, O. (2018) · Oncology Letters · doi:10.3892/ol.2018.8653 · Cited by 13

Thyroid Cancer Cell Line Misidentification: An Update

Schweppe, R. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4182 · Cited by 11

The Author Response Antiproliferation and Redifferentiation in Thyroid Cancer Cell

Phytochemicals, L. P., Kang, H. J., Youn, Y.-K., Hong, M.-K., & Kim, L. S. (2013)

The Author Response: Antiproliferation and Redifferentiation in Thyroid Cancer Cell Line by Polyphenol Phytochemicals

Kang, H. J., Youn, Y., Hong, M.-K., & Kim, L. S. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.10.1398 · Cited by 2

Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts

Marlow, L. A., Rohl, S. D., Miller, J. L., Knauf, J. A., Fagin, J. A., Ryder, M. M., Milosevic, D., Netzel, B. C., Grebe, S. K. G., Reddi, H. V., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01845 · Cited by 19

Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples

Ribeiro, F. R., Meireles, A. M., Rocha, A. S., & Teixeira, M. R. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-371 · Cited by 41